title: Synthetic approaches to the 2011 new drugs.
abstract: New drugs are introduced to the market every year and each represents a privileged structure for its biological target. These new chemical entities (NCEs) provide insights into molecular recognition and also serve as leads for designing future new drugs. This review covers the synthesis of 26 NCEs that were launched in the world in 2011.
authors.affiliation: Shenogen Pharma Group, Beijing, China. Hongxia.ding@shenogen.com
authors.forename: Hong X
authors.initials: HX
authors.lastname: Ding
authors.forename: Kevin K-C
authors.initials: KK
authors.lastname: Liu
authors.forename: Subas M
authors.initials: SM
authors.lastname: Sakya
authors.forename: Andrew C
authors.initials: AC
authors.lastname: Flick
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: O'Donnell
mesh_terms: D017277:Drug Approval; D015195:Drug Design; D006801:Humans; D004364:Pharmaceutical Preparations / Q000138:chemical synthesis*
chemical_list: D004364:Pharmaceutical Preparations